Mechanistic Determinants of Biotherapeutics Absorption Following SC Administration

Overview of attention for article published in The AAPS Journal, May 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

policy: 1 policy source
twitter: 3 X users

patent: 39 patents

Citations

dimensions_citation: 260 Dimensions

Readers on

mendeley: 307 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 39 patents that reference this research output.

Mechanistic Determinants of Biotherapeutics Absorption Following SC Administration

About this Attention Score

Mentioned by

Citations

Readers on

Molecular biomarkers for cancer immunotherapy

Grant US-11939637-B2

United States of America

Compositions and methods for diagnosing, evaluating and treating cancer by means of the…

Grant US-11834718-B2

United States of America

Neoantigens and uses thereof

Grant US-11793867-B2

United States of America

Surfaces having reduced non-specific binding and antigenicity

Grant US-11752213-B2

United States of America

Polymorphic gene typing and somatic change detection using sequencing data

Grant US-11725237-B2

United States of America

Order and disorder as a design principle for stimuli-responsive biopolymer networks

Grant US-11680083-B2

United States of America

Use of IL-22 dimer in manufacture of a medicament for intravenous administration

Grant US-11654104-B2

United States of America

Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature…

Grant US-11648200-B2

United States of America

Dual agonist fusion proteins

Grant US-11649275-B2

United States of America

Recombinant production of hybrid lipid-biopolymer materials that self-assemble and…

Grant US-11554097-B2

United States of America

Pharmaceutical formulations of C1 esterase inhibitor

Grant US-11554156-B2

United States of America

Compositions and methods for detecting a mutant variant of a polynucleotide

Grant US-11549149-B2

United States of America

Methods of treating psoriasis using IL-17 antagonists

Grant US-11534490-B2

United States of America

Methods of treating ankylosing spondylitis using IL-17 antagonists

Grant US-11534491-B2

United States of America

Amphiphilic polynucleotides

Grant US-11512314-B2

United States of America

Use of IL-22 in treating necrotizing enterocolitis

Grant US-11510966-B2

United States of America

Nonfouling biosensors

Grant US-11467156-B2

United States of America

Genetically encoded intrinsically disordered stealth polymers for delivery and methods of…

Grant US-11458205-B2

United States of America

Combination therapy with neoantigen vaccine

Grant US-11452768-B2

United States of America

Method for treating rheumatoid arthritis by administering IL-6 receptor antibodies

Grant US-11149089-B2

United States of America

Subcutaneous therapeutic enzyme formulations, uses, and methods for generating thereof

Grant US-11065309-B2

United States of America

Pharmaceutical compositions comprising a polypeptide that binds to IL-6

Grant US-11008393-B2

United States of America

Methods for profiling the t cell repertoire

Grant US-10993997-B2

United States of America

Molecular biomarkers for cancer immunotherapy

Grant US-10975442-B2

United States of America

Shared neoantigens

Grant US-10835585-B2

United States of America